Advertisement
Screener

TAKEDA PHARMACEUTICAL CO LTD Current Holdings: USA Stocks

TAKEDA PHARMACEUTICAL CO LTD current holdings: USA Stocks

TAKEDA PHARMACEUTICAL CO LTD reported $0.01 billion in share positions in stocks (listed in the US), 6 positions, in its Form 13F for the quarter ended 2025-09-30; the largest are OVID, EQ, STTK.

  • OVID: Country of operation United States; Class COM; Shares 7,531,996; Value $9,791,595.
  • EQ: Country of operation United States; Class COM; Shares 1,824,977; Value $2,609,717.
  • STTK: Country of operation United States; Class COM; Shares 515,619; Value $1,232,329.
  • AMWL: Country of operation United States; Class COM; Shares 77,733; Value $478,061.

Form 13F-HR as filed (SEC CIK 1395064): quarter ended 2025-09-30, filed 2025-11-13. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.

Performance is each holding's price change from its close on the 2025-09-30 quarter end to its latest retained close (2026-09-29, or the date shown for a stock that stopped trading). Price only; dividends are not included. A stock that split in the period is restated by the split ratio in its own Form 8-K; a dash marks a holding with no retained closes.

StockCountry of operationClassSharesValue% of listedQuarter endFiledPerformance
OVID
Ovid Therapeutics, Inc.
United StatesCOM7,531,996$9,791,59568.79%2025-09-302025-11-13+95.38%
EQ
Equillium, Inc.
United StatesCOM1,824,977$2,609,71718.33%2025-09-302025-11-13+13.29%
STTK
Shattuck Labs, Inc.
United StatesCOM515,619$1,232,3298.66%2025-09-302025-11-13+173.64%
AMWL
American Well Corporation
United StatesCOM77,733$478,0613.36%2025-09-302025-11-13+113.66%
RANI
Rani Therapeutics Holdings, Inc.
United StatesCOM203,190$101,5540.71%2025-09-302025-11-13— split 2025-10-17, ratio not on file
LAB
Standard Biotools, Inc.
United StatesCOM16,515$21,4700.15%2025-09-302025-11-13-45.38%

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet